Healthcare Tips: Drugmakers can't charge beyond making costs for compassionate use: FDA

(Reuters) - The U.S. Food and Drug Administration said companies could only charge patients for the cost of manufacturing experimental treatments used under compassionate grounds, and it cannot force government or private health insurers to pay for these drugs.

Read more: Drugmakers can't charge beyond making costs for compassionate use: FDA